[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100505213":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":38,"responsibleParty":55,"collaborators":18,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":18,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":78,"overallStatus":40,"whyStopped":18,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Centre Leon Berard","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A : former patients with multidisciplinary day hospitalization","EXPERIMENTAL","In this group, a multidisciplinary day hospitalization will be programmed after the end-of-treatment evaluation and 2 months after the end of treatment at the latest. This day hospitalization will consist at least of a psychological interview, an interview with a social worker and a medical interview.",[13],"Other: Multidisciplinary day hospitalization",{"label":15,"type":16,"description":17,"interventionNames":18},"Group B : former patients without multidisciplinary day hospitalization","NO_INTERVENTION","In this group, the former patients will experiment the standard of care, with an oncological follow-up.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Multidisciplinary day hospitalization","This multidisciplinary day hospitalization will consist at least of a psychological interview, an interview with a social worker and a medical interview. The objectives of this medical interview, conducted by a clinician researcher, are to summarize the pathology, the treatment(s) received, and to develop a personalized after-cancer plan.\n\nThe psychological interview will assess the needs for further care, and will refer the former patient if necessary.\n\nThe social interview will take stock of the former patient's return to school and\u002For professional life, and direct him\u002Fher to possible applications for social assistance if needed.\n\nIf needs of supportive care emerge from the history of treatment period, some consultations can be added during the day hospitalization, like an interview with a dietician or an adapted physical activity assessment.",[9],[25],{"name":26,"affiliation":27,"role":28},"Amandine BERTRAND, MD","Institut d'Hématologie et d'Oncologie Pédiatrique","PRINCIPAL_INVESTIGATOR",[30,35],{"name":26,"role":31,"phone":32,"phoneExt":33,"email":34},"CONTACT","04787872606","+33","Amandine.BERTRAND@ihope.fr",{"name":36,"role":31,"phone":18,"phoneExt":18,"email":37},"Véronique CHRISTOPHE, PU","veronique.christophe@lyon.unicancer.fr",[39],{"facility":5,"status":40,"city":41,"state":18,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Lyon","69008","France","FR",{"type":46,"coordinates":47},"Point",[48,49],4.84789,45.74906,{"lat":49,"lon":48},[52],{"name":53,"role":31,"phone":54,"phoneExt":18,"email":18},"Amandine Bertrand, MD","+33478782606",{"type":56,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100505213","impact-of-a-multidisciplinary-end-of-treatment-day-hospital-on-the-quality-of-life-of-adolescents-and-young-adults-with-cancer-100505213",false,"NCT05858424","Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer","Impact Evaluation of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer","HOPAYA","Inclusion Criteria:\n\n1. Be aged between 15 and 25 years at diagnosis. This age range corresponds to the one chosen at the Leon Berard comprehensive cancer care center (CLB) for support in the AYA Department.\n2. Be previously treated at the Paediatric Hematology and Oncology Institute (IHOPe) and\u002For at CLB in AYA Department\n3. For a solid tumor or a lymphoma\n4. Be in complete oncological response at the end of treatment; have received their end-of-treatment evaluation\n5. Have finished their therapy since less than 2 months (therapy is defined by any treatment received, including maintenance)\n6. Be capable of understanding, reading and writing French\n7. Be affiliated to a health insurance plan\n8. Have been informed of the study and have consented to it\n9. For minor patients, consent of parents and\u002For legal tutors must be collected.\n\nExclusion Criteria:\n\n1. cannot be followed-up throughout the duration of the study (12 months),\n2. be deprived of liberty by a court or administrative decision,\n3. have not consent to participate or are incapable of objecting in an informed manner.","ALL","15 Years","25 Years",{"count":69,"type":70},214,"ESTIMATED","INTERVENTIONAL",[73],"NA","Rational: 800 cases of cancer per year are diagnosed in France among Adolescents and Young Adults (AYA). This population has been specifically targeted since 2008 by the INCa, leading to the development of structures entirely dedicated to its management. Indeed, the occurrence of cancer in this period of transition leads to specific problems, which require a special attention. The various measures taken since then (Cancer Plan 2014-2019, DGOS instruction in 2016, 10-year strategy to fight cancer 2021-2030) have enabled the implementation of multidisciplinary structures, resulting in better access to care, and consideration of the social, family and relational dimensions of this population. However, the transition from the end of oncology treatment to the follow-up period remains a sensitive period, generating both positive (relief, joy) and negative feelings (uncertainty, feelings of abandonment, anxiety).\n\nThe investigators therefore hypothesize that the creation of a multidisciplinary end-of-treatment day hospital (DH) involving at least one medical interview, one psychological consultation and one social interview, would improve the quality of life of these former patients during the first year of oncology follow-up.\n\nMethod: This is a clinical research study conducted in a single centre. At their last visit for treatment, the study will be offered to patients. If the participants agree to participate, they will be randomized to benefit from DH in addition to their planned follow-up with their oncologist. The main objective is to compare the quality of life of former patients according to participation in DH or not. 210 patients will be included for a 20-month recruitment period.\n\nExpected results: Throughout the development of DH, the investigators plan to improve the quality of life of former patients during this transitional phase.",[76,77],"Solid Tumor","Lymphoma",[79,80,81,82,83,84],"Survivorship","Supportive care needs","Adolescents and Young Adults","Post-treatment","Oncology","Quality of life","2026-04-17",{"date":87,"type":88},"2026-04-22","ACTUAL",{"date":90,"type":88},"2022-11-29",{"date":92,"type":70},"2026-09",{"name":5,"class":6},1]